Trial Profile
The Durability of Early RA Disease Control After Tocilizumab Withdrawal: A Canadian Experience
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 17 Apr 2017
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 17 Apr 2017 New trial record